Dare Bioscience, Inc. — Director's Dealing 2022

Jan 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2022-01-25

Reporting Person: Fair John A (Chief Strategy Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-25	Stock Option (right to buy)	$1.59	A	185000	Acquired	2032-01-25	Common stock (185000.0)	Direct

Footnotes

F1: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.